Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -43.11% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -43.11% | -- | -- | -- |
| Cost of Revenue | -34.86% | -39.35% | -13.94% | 28.53% | 57.15% |
| Gross Profit | 23.30% | 38.63% | 22.26% | -18.31% | -33.45% |
| SG&A Expenses | -11.62% | -22.97% | -11.18% | 4.69% | -0.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.88% | -32.14% | -12.73% | 18.81% | 28.51% |
| Operating Income | 18.32% | 31.06% | 17.41% | -12.75% | -16.63% |
| Income Before Tax | 16.49% | -134.20% | 14.03% | -18.23% | -19.69% |
| Income Tax Expenses | -- | 517.48% | -- | -96.67% | -- |
| Earnings from Continuing Operations | 16.09% | -136.06% | 13.99% | -18.07% | -19.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.09% | -136.06% | 13.99% | -18.07% | -19.58% |
| EBIT | 18.32% | 31.06% | 17.41% | -12.75% | -16.63% |
| EBITDA | 15.71% | 30.08% | 19.48% | -10.99% | -14.80% |
| EPS Basic | 32.11% | -134.84% | 14.80% | -12.99% | -2.20% |
| Normalized Basic EPS | 32.43% | 29.77% | 14.84% | -13.14% | -2.29% |
| EPS Diluted | 32.11% | -134.84% | 14.80% | -12.99% | -2.20% |
| Normalized Diluted EPS | 32.43% | 29.77% | 14.84% | -13.14% | -2.29% |
| Average Basic Shares Outstanding | 23.60% | 0.51% | 0.95% | 4.50% | 17.02% |
| Average Diluted Shares Outstanding | 23.60% | 0.51% | 0.95% | 4.50% | 17.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |